Bg pattern

SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Sapropterina Dipharma 100 mg Powder for Oral Solution

Sapropterina Dipharma 500 mg Powder for Oral Solution

sapropterin dihydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Sapropterina Dipharma and what is it used for
  2. What you need to know before you take Sapropterina Dipharma
  3. How to take Sapropterina Dipharma
  4. Possible side effects
  5. Storage of Sapropterina Dipharma
  6. Contents of the pack and other information

1. What is Sapropterina Dipharma and what is it used for

Sapropterina Dipharma contains the active substance sapropterin, which is a synthetic copy of a substance naturally found in the body called tetrahydrobiopterin (BH4). BH4 is necessary in the body to convert an amino acid called phenylalanine into another amino acid called tyrosine.

Sapropterina Dipharma is used to treat hyperphenylalaninemia (HPA) or phenylketonuria (PKU) in patients of any age. HPA and PKU are due to abnormally high levels of phenylalanine in the blood that can be harmful. Sapropterina Dipharma reduces these levels in some patients who respond to BH4 and may help increase the amount of phenylalanine that can be included in the diet.

This medicine is also used to treat a hereditary disease called BH4 deficiency in patients of any age, in which the body cannot produce enough BH4. Because BH4 levels are very low, the body cannot properly use phenylalanine and levels of this amino acid increase, having harmful effects. By replacing the BH4 that the body cannot produce, Sapropterina Dipharma reduces the harmful excess of phenylalanine in the blood and increases tolerance to dietary phenylalanine.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Sapropterina Dipharma

Do not take Sapropterina Dipharma

  • if you are allergic to sapropterin or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting treatment with Sapropterina Dipharma, especially:

  • if you are 65 years of age or older
  • if you have kidney or liver problems
  • if you are ill. It is recommended to consult with your doctor in case of illness as blood phenylalanine levels may increase
  • if you have a predisposition to seizures

When you receive treatment with Sapropterina Dipharma, your doctor will perform blood tests to check the content of phenylalanine and tyrosine and decide whether to adjust the dose of Sapropterina Dipharma or the diet if necessary.

You must continue dietary treatment as recommended by your doctor. Do not change your diet without telling your doctor. Even if you take Sapropterina Dipharma, if your blood phenylalanine levels are not well controlled, you may have serious neurological problems. Your doctor must continue to monitor your blood phenylalanine levels frequently during treatment with Sapropterina Dipharma, to ensure they are not too high or too low.

Using Sapropterina Dipharma with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. In particular, you should tell your doctor if you are using:

  • levodopa (for the treatment of Parkinson's disease)
  • cancer treatments (e.g., methotrexate)
  • antibiotics (e.g., trimethoprim)
  • medicines that cause blood vessels to dilate (e.g., glyceryl trinitrate [GTN], isosorbide dinitrate [ISDN], sodium nitroprusside [SNP], molsidomine, minoxidil).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

If you are pregnant, your doctor will tell you how to properly control phenylalanine levels. If they are not strictly controlled before pregnancy or when you become pregnant, it can be harmful to you and your baby. Your doctor will monitor dietary restriction of phenylalanine intake before and during pregnancy.

If a strict diet does not satisfactorily reduce the amount of phenylalanine in the blood, your doctor will consider whether you should take this medicine.

You should not use this medicine during breastfeeding.

Driving and using machines

Sapropterina Dipharma is not expected to affect your ability to drive or use machines.

Sapropterina Dipharma contains potassium

Sapropterina Dipharma 100 mg powder for oral solution

This medicine contains 0.3 mmol (11.7 mg) of potassium per sachet, which should be taken into account in patients with renal insufficiency or in patients with low-potassium diets.

Sapropterina Dipharma 500 mg powder for oral solution

This medicine contains 1.6 mmol (62.6 mg) of potassium per sachet, which should be taken into account in patients with renal insufficiency or in patients with low-potassium diets.

3. How to take Sapropterina Dipharma

Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor again.

Sapropterina Dipharma 500 mg should only be used in patients with a body weight over 25 kg.

Dose for PKU

The recommended initial dose of Sapropterina Dipharma in patients with PKU is 10 mg per kg of body weight. Take Sapropterina Dipharma once a day, with a meal to increase absorption, and at the same time each day, preferably in the morning. Your doctor may adjust the dose, usually between 5 and 20 mg daily per kg of body weight, according to your condition.

Dose for BH4 deficiency

The recommended initial dose of Sapropterina Dipharma in patients with BH4 deficiency is 2 to 5 mg per kg of body weight. Take Sapropterina Dipharma with a meal to increase absorption. Divide the total daily dose into 2 or 3 doses administered throughout the day. Your doctor may adjust the dose up to 20 mg daily per kg of body weight, according to your condition.

The following table is an example of how to calculate the appropriate dose

Body weight

(kg)

Number of 100 mg sachets

(dose of 10 mg/kg)

Number of 100 mg sachets

(dose of 20 mg/kg)

Number of 500 mg sachets

(dose of 10 mg/kg)

Number of 500 mg sachets

(dose of 20 mg/kg)

10

1

2

-

-

20

2

4

-

-

30

3

6

-

-

40

4

8

-

-

50

5

10

1

2

Method of administration

For patients with PKU, the total daily dose is taken once a day and at the same time each day, preferably in the morning.

For patients with BH4 deficiency, the total daily dose is divided into 2 or 3 doses distributed throughout the day.

Use in patients with a body weight over 20 kg

Make sure you know the dose of Sapropterina Dipharma powder that your doctor has prescribed.

Sapropterina Dipharma 100 mg powder for oral solution

For higher doses, your doctor may also prescribe Sapropterina Dipharma 500 mg powder for oral solution.

Sapropterina Dipharma 500 mg powder for oral solution

For the exact dose, your doctor may also prescribe Sapropterina Dipharma 100 mg powder for oral solution.

Make sure you know how to use Sapropterina Dipharma 100 mg or 500 mg powder for oral solution or both medicines to prepare the dose.

Open the sachet (or sachets) only when you are about to use it (them).

Preparation of the sachet (or sachets)

  • Open the Sapropterina Dipharma powder sachet (or sachets) for oral solution by folding and tearing, or by cutting along the dotted line at the top corner of the sachet.
  • Empty the contents of the sachet (or sachets) into 120 to 240 ml of water. After dissolving the powder in water, the resulting solution should be clear, colorless to yellowish.

Intake of the medicine

  • Drink the solution within 30 minutes.

Use in children up to 20 kg body weight

Use only the 100 mg sachets if you are preparing Sapropterina Dipharma for children with a body weight of up to 20 kg.

The dose is based on body weight, which will change as the child grows. Your doctor will tell you:

  • the number of Sapropterina Dipharma 100 mg sachets needed for a dose
  • the amount of water needed to mix a dose of Sapropterin Dipharma
  • the amount of solution to administer to the child for the prescribed dose.

The child should drink the Sapropterina Dipharma solution with a meal.

Administer the prescribed amount of solution to the child within 3 minutes of dissolution. If you cannot administer the dose to the child within 30 minutes of dissolving the powder, you will need to prepare a new solution, as the unused solution should not be used after 30 minutes.

Materials needed to prepare and administer the dose of Sapropterin Dipharma to the child

  • The number of Sapropterina Dipharma 100 mg sachets needed for a dose
  • A medicine cup with graduated markings corresponding to 20, 40, 60, and 80 ml
  • A glass or cup
  • A spoon or clean utensil for stirring
  • An oral syringe (graduated in 1 ml divisions) (a 10 ml syringe for administration of volumes ≤ 10 ml or a 20 ml syringe for administration of volumes > 10 ml)

Ask your doctor for the medicine cup and the 10 ml or 20 ml oral syringe if you do not have these materials.

Steps for preparation and intake of the dose:

  • Place the prescribed Sapropterina Dipharma 100 mg sachets in the medicine cup. Pour the amount of water indicated by your doctor (e.g., if your doctor told you to use 20 ml to dissolve a Sapropterin Dipharma sachet) into the measuring glass. Check that the amount of liquid aligns (at the graduated marking on the medicine cup) with the amount indicated by your doctor. Stir with the spoon or clean utensil until the powder dissolves. After dissolving the powder in water, the resulting solution should be clear, colorless to yellowish.
  • If your doctor told you to administer only part of the solution, insert the tip of the oral syringe into the medicine cup. Slowly pull the plunger back to draw the amount indicated by your doctor.
  • Then transfer the solution to a glass or medicine cup by slowly pushing the plunger until all the solution previously drawn into the oral syringe is inside (e.g., if your doctor told you to dissolve two Sapropterina Dipharma 100 mg sachets in 40 ml of water and administer 30 ml to the child, you will need to use the 20 ml oral syringe twice to draw the 30 ml [e.g., 20 ml + 10 ml] of solution and transfer it to a glass or medicine cup). Use a 10 ml oral syringe for administration of volumes ≤ 10 ml or a 20 ml oral syringe for administration of volumes > 10 ml.
  • If the baby is too small to drink from a glass or cup, you can administer the solution using the oral syringe. Draw the prescribed volume of solution prepared in the medicine cup into the oral syringe and insert the tip of the oral syringe into the baby's mouth. Aim the tip of the oral syringe towards one of the cheeks. Slowly push the plunger, so that a small amount is released at a time, until all the solution contained in the oral syringe is administered.
  • Discard any remaining solution. Pull the plunger out of the oral syringe body. Wash both parts of the oral syringe and the medicine cup with warm water and let them air dry. When the oral syringe is dry, put the plunger back into the oral syringe body. Store the oral syringe and medicine cup for the next use.

If you take more Sapropterina Dipharma than you should

If you take more Sapropterina Dipharma than prescribed, you may experience side effects that can include headache and dizziness. If you take more Sapropterina Dipharma than prescribed, tell your doctor or pharmacist immediately.

If you forget to take Sapropterina Dipharma

Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.

If you stop taking Sapropterina Dipharma

Do not stop treatment with Sapropterina Dipharma without discussing it with your doctor first, as blood phenylalanine levels may increase.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

There have been a few reports of allergic reactions (such as skin rash and severe reactions). The frequency is not known (frequency cannot be estimated from the available data).

If you have inflamed, reddened, and severely itchy areas (hives), runny nose, rapid or irregular heartbeat, swelling of the tongue or throat, sneezing, wheezing, severe breathing difficulties, or dizziness, you may be experiencing a severe allergic reaction to the medicine. If you experience these symptoms, consult your doctor immediately.

Very common side effects (may affect more than 1 in 10 people)

Headache and runny nose.

Common side effects (may affect up to 1 in 10 people)

Sore throat, nasal congestion or stuffiness, cough, diarrhea, vomiting, stomach pain, low phenylalanine levels in blood tests, indigestion, and general discomfort (nausea) (see section 2: "Warnings and precautions").

Unknown frequency (cannot be estimated from the available data)

Gastritis (inflammation of the stomach lining), esophagitis (inflammation of the esophagus lining).

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Sapropterina Dipharma

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the sachet and on the carton after EXP. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Sapropterina Dipharma

  • The active substance is sapropterin dihydrochloride.

Sapropterina Dipharma 100 mg:Each sachet contains 100 mg of sapropterin dihydrochloride (equivalent to 77 mg of sapropterin).

Sapropterina Dipharma 500 mg:Each sachet contains 500 mg of sapropterin dihydrochloride (equivalent to 384 mg of sapropterin).

  • The other ingredients are mannitol (E421), potassium citrate (E332), sucralose (E955), and ascorbic acid (E300). See section 2: "Sapropterina Dipharma contains potassium".

Appearance and packaging

The powder for oral solution is white to yellowish in color. The powder is in single-dose sachets containing 100 mg or 500 mg of sapropterin dihydrochloride.

Packs of 30 sachets.

Marketing Authorisation Holder

Dipharma Arzneimittel GmbH

Offheimer Weg 33

65549 Limburg a. d. Lahn

Germany

Manufacturer

Depo-Pack S.r.l.

Via Giovanni Morandi 28

21047 Saronno (VA)

Italy

or

Pharmadox Healthcare Ltd.

KW20A Kordin Industrial Park

Paola, PLA 3000

Malta

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.

Online doctors for SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER

Discuss questions about SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER?
SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER?
The active ingredient in SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER is sapropterin. This information helps identify medicines with the same composition but different brand names.
Who manufactures SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER?
SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER is manufactured by Dipharma Arzneimittel Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SAPROPTERIN DIPHARMA 100 MG ORAL SOLUTION POWDER?
Other medicines with the same active substance (sapropterin) include KUVAN 100 mg SOLUBLE TABLETS, SAPROPTERIN AUROVITAS 100 mg SOLUBLE TABLETS, SAPROPTERIN DIPHARMA 100 mg SOLUBLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media